P
603566
vs
S
Shanghai Composite
Over the past 12 months, Pulike Biological Engineering Inc has underperformed Shanghai Composite, delivering a return of +13% compared to the Shanghai Composite's +22% growth.
Stocks Performance
603566 vs Shanghai Composite
Performance Gap
603566 vs Shanghai Composite
Performance By Year
603566 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.